Which NSAID is used for pain management in corneal foreign body treatment?

Which NSAID is used for pain management in corneal foreign body treatment?

• A. Ketorolac 0.5% qid
• B. Diclofenac 0.1% qid
• C. Ibuprofen orally
• D. Naproxen orally

Answer: (A)

Pain on the ocular surface after a corneal foreign body is best addressed with a topical anti-inflammatory that acts directly where the injury lies. Ketorolac 0.5% given four times daily is a well-established topical NSAID for this purpose. It inhibits prostaglandin synthesis on the cornea and conjunctiva, reducing both pain and inflammation at the source without relying on systemic absorption. This direct, local action provides rapid relief after foreign body removal and minimizes systemic side effects that come with oral NSAIDs. Although another topical NSAID and oral NSAIDs exist, the topical ketorolac formulation is the standard choice for corneal surface pain because it targets the eye specifically and has broad clinical support for this setting. Oral NSAIDs deliver slower, less targeted relief and carry systemic risks, while the other topical options may not be as routinely used or as well established for this exact scenario. Short-term use of topical NSAIDs is generally appropriate, but they should be used with caution if there are corneal ulcers or epithelial defects, as well as to monitor for local irritation.

Pain on the ocular surface after a corneal foreign body is best addressed with a topical anti-inflammatory that acts directly where the injury lies. Ketorolac 0.5% given four times daily is a well-established topical NSAID for this purpose. It inhibits prostaglandin synthesis on the cornea and conjunctiva, reducing both pain and inflammation at the source without relying on systemic absorption. This direct, local action provides rapid relief after foreign body removal and minimizes systemic side effects that come with oral NSAIDs.

Although another topical NSAID and oral NSAIDs exist, the topical ketorolac formulation is the standard choice for corneal surface pain because it targets the eye specifically and has broad clinical support for this setting. Oral NSAIDs deliver slower, less targeted relief and carry systemic risks, while the other topical options may not be as routinely used or as well established for this exact scenario. Short-term use of topical NSAIDs is generally appropriate, but they should be used with caution if there are corneal ulcers or epithelial defects, as well as to monitor for local irritation.